|
CNOT8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.791700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.879800E-03 |
| Normal-vs-Stage2 |
2.938000E-01 |
| Normal-vs-Stage3 |
5.141600E-01 |
| Normal-vs-Stage4 |
7.163000E-01 |
| Stage1-vs-Stage2 |
4.103000E-01 |
| Stage1-vs-Stage3 |
1.496970E-01 |
| Stage1-vs-Stage4 |
6.338100E-02 |
| Stage2-vs-Stage3 |
7.203000E-01 |
| Stage2-vs-Stage4 |
3.314800E-01 |
| Stage3-vs-Stage4 |
4.394400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.607600E-02 |
| Normal-vs-AfricanAmerican |
1.677190E-01 |
| Normal-vs-Asian |
5.762000E-01 |
| Caucasian-vs-AfricanAmerican |
6.665000E-01 |
| Caucasian-vs-Asian |
7.134800E-01 |
| AfricanAmerican-vs-Asian |
8.223600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.081900E-02 |
| Normal-vs-Female |
7.991000E-01 |
| Male-vs-Female |
4.502600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.618200E-02 |
| Normal-vs-Extreme_Weight |
1.126060E-02 |
| Normal-vs-Obese |
2.077200E-01 |
| Normal-vs-Extreme_Obese |
3.122200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.586400E-01 |
| Normal_Weight-vs-Obese |
5.254400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.681400E-01 |
| Extreme_Weight-vs-Obese |
1.301820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.808400E-01 |
| Obese-vs-Extreme_Obese |
2.018600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.566400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.334800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.676410E-02 |
| Normal-vs-Age(81-100Yrs) |
1.730170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.580800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.502100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.696500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.822640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.810200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.596200E-03 |
| Normal-VS-Type2 PRCC |
4.847600E-02 |
| Normal-VS-KIRP CIMP |
5.788400E-01 |
| Normal-VS-Unclassified PRCC |
8.441400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.485800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.725600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.100500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.397240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.776390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.301200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.055820E-02 |
| Normal-vs-N1 |
4.939800E-01 |
| Normal-vs-N2 |
9.476000E-01 |
| N0-vs-N1 |
6.561000E-03 |
| N0-vs-N2 |
2.762400E-01 |
| N1-vs-N2 |
8.018800E-01 |
|
|
